Vice President of Genomic Research & Development, Expression Analysis
Patrick Hurban, Ph.D., is vice president and global head of genomic research and development at Expression Analysis, a Q2 Solutions Quintiles Quest Joint Venture Company. In this role, he is responsible for the identification and implementation of new genomic capabilities, the development and validation of genomic assays. These include broad-based screening assays such as exome and RNA sequencing, as well as microarray-based expression profiling and genotyping, to highly targeted assays. Dr. Hurban has more than 25 years of experience in molecular genetics, including over 15 years in positions of increasing responsibility in high-profile genomics-focused organizations. His research interests have focused on the genetic control of gene expression and have spanned diverse fields such as toxicology, developmental and cancer biology.
Following a bachelor’s degree in biology from the University of North Carolina at Chapel Hill, he earned his Ph.D. in human genetics from the University of Utah in Salt Lake City before serving as a postdoctoral research fellow of the American Cancer Society in the Department of Developmental Biology at Stanford University.